<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29577" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Strongyloidiasis (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gonzales</surname>
            <given-names>Daphne Joyce</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chakraborty</surname>
            <given-names>Rebanta K.</given-names>
          </name>
          <aff>Steward Medical\Good Samaritan Medical</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Climaco</surname>
            <given-names>Antonette</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Daphne Joyce Gonzales declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rebanta Chakraborty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Antonette Climaco declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>12</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29577.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Strongyloidiasis is a disease caused by the intestinal nematodes&#x000a0;<italic toggle="yes">Strongyloides stercoralis&#x000a0;</italic>or&#x000a0;<italic toggle="yes">Strongyloides&#x000a0;fuelleborni.&#x000a0;</italic>The more common agent,&#x000a0;<italic toggle="yes">S</italic><italic toggle="yes">tercoralis</italic><italic toggle="yes">&#x000a0;stercoralis</italic>, is&#x000a0;a helminth&#x000a0;transmitted by soil and can cause severe disease in immunocompromised individuals.<xref ref-type="bibr" rid="article-29577.r1">[1]</xref><xref ref-type="bibr" rid="article-29577.r2">[2]</xref><xref ref-type="bibr" rid="article-29577.r3">[3]</xref></p>
      </sec>
      <sec id="article-29577.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Strongyloides stercoralis&#x000a0;</italic>is a nematode with a complicated life cycle that involves parasitic and free-living forms. It can cause autoinfection, which is the ability to complete a full life cycle within humans and, therefore, multiplies. Multiple migratory cycles can lead to recurrent infections. Only a complete cure can eliminate the risk of complications, so accurate diagnostic methods must&#x000a0;be employed.<xref ref-type="bibr" rid="article-29577.r4">[4]</xref><xref ref-type="bibr" rid="article-29577.r5">[5]</xref><xref ref-type="bibr" rid="article-29577.r6">[6]</xref></p>
      </sec>
      <sec id="article-29577.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Endemic to the Caribbean, Latin America, Europe, Asia, and sub-Saharan Africa, strongyloidiasis mainly affects tropical and sub-tropical regions. It is estimated that&#x000a0;<italic toggle="yes">S. stercoralis&#x000a0;</italic>affects&#x000a0;30 to 100 million people worldwide. It is often underdiagnosed, and more appropriate and&#x000a0;sensitive diagnostic tests would&#x000a0;yield a higher global incidence.<xref ref-type="bibr" rid="article-29577.r7">[7]</xref></p>
        <p>Environmental risk factors in endemic regions include close exposure to soil and sand for occupational needs, proximity to farm animals, overcrowding, and poor sanitation. A low socio-economic population is, therefore, more vulnerable. For the same reason, children are affected more due to poor adherence to personal hygiene. The male sex is infected twice as more due to occupational exposure. Certain soil-grown vegetables and even tap water have been identified with S. stercoralis larvae, eggs, and even adult nematodes. While prevalent in all continents, in the&#x000a0;United States, the parasite has been particularly identified in Appalachia and the southeastern United States.[8]</p>
      </sec>
      <sec id="article-29577.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The life cycle of <italic toggle="yes">S. stercoralis</italic> has three components: direct, indirect, and autoinfection. In the direct cycle, <bold>the rhabditiform larva</bold> from stool matures into filariform larvae in the soil and penetrates the skin to travel to the lungs and, eventually, the gastrointestinal system. The indirect cycle follows, where eggs are excreted and returned to the soil to live as free-living adults or develop into filariform larvae or reinvade the host through the perianal skin. This reinvasion characterizes the autoinfection cycle, where the infective filariform larva&#x000a0;completes its formation in the host&#x02019;s intestines.</p>
        <p>Direct contact of intact skin with contaminated soil results in inoculation of the larva, which then migrates through lymphatics and venules to reach pulmonary circulation and then alveoli. Larvae are then coughed up proximally into the trachea and then swallowed from the upper respiratory tract into the gastrointestinal tract. Within the intestine, they mature, and eggs are produced by females.</p>
        <list list-type="order">
          <list-item>
            <p>Eggs may pass intact through stool</p>
          </list-item>
          <list-item>
            <p>Eggs may hatch in the intestine and pass in stool as rhabditiform larva</p>
          </list-item>
          <list-item>
            <p>Or produce infective filariform larva prematurely,&#x000a0; which then reinvades the host either via the intestinal wall or perianal skin to create a perpetual cycle of infection known as <bold>autoinfection</bold>.</p>
          </list-item>
        </list>
        <p>The rhabditiform larva is the initial noninfective stage, whereas the filariform larva is the infective stage. The incubation period ranges between 2 to 4 weeks which is almost the same for autoinfection as well. Autoinfection usually occurs in individuals with impaired cell-mediated immunity. It is the key pathway to both hyperinfection syndrome and disseminated strongyloidiasis.</p>
      </sec>
      <sec id="article-29577.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Among individuals who have asymptomatic chronic infection, incidental diagnosis of peripheral eosinophilia is the most common presentation. However, at the acute stage, infected individuals may have a pruritic edematous petechial rash at the site of penetration. A more pathognomonic rash is <italic toggle="yes"><bold>larva currens</bold></italic>&#x000a0;or <italic toggle="yes"><bold>migrans</bold></italic> from the migration of the filariform larva under the skin resulting in a hypersensitivity response in the host. It results in a transient linear erythematous serpiginous rash that shifts at a rate of 2-10 cm/hour. The duration of the rash can be hours to days at a time, but it can be a recurrent process during the duration of parasitic autoinfection.<xref ref-type="bibr" rid="article-29577.r8">[8]</xref><xref ref-type="bibr" rid="article-29577.r9">[9]</xref><xref ref-type="bibr" rid="article-29577.r10">[10]</xref></p>
        <p>Chronic infection can have nonspecific multiorgan symptoms predominantly of gastrointestinal, dermatological, or respiratory systems. Abdominal bloating, heartburn, constipation or diarrhea, and reduced appetite are the usual gastrointestinal symptoms. They take about 2 weeks to manifest after the initial infection. A chronic dry cough or wheezing that mimics asthma can be the respiratory manifestation, whereas constitutional symptoms of low-grade fever, weight loss, and anemia can also be the sole presenting feature. Larva migrating through pulmonary capillaries can produce alveolar hemorrhage, while their entrance into alveolar spaces causes an eosinophilic inflammatory response resulting in clinical evidence of pneumonitis.</p>
        <p>A more ominous presentation is of <bold>hyper infection syndrome,</bold> which is characterized by an explosive increase in the multiplication of infective larvae and, thus, the worm burden within a host. Although it has occasionally been reported in immunocompetent hosts, it is usually seen in immunocompromised individuals, particularly those on high-dose systemic steroids or immunosuppressants after solid organ transplant. The initial low-grade gastrointestinal and respiratory symptoms of chronic infection suddenly progress to complications of intestinal obstruction, peritonitis, gastrointestinal bleeding, pneumonitis, alveolar hemorrhage, respiratory failure, or sepsis. <bold>Disseminated strongyloidiasis</bold>, on the other hand, involves dissemination outside locations involved in the parasite&#x02019;s ordinary life cycle. Translocation can result in bloodborne infection, massive weight loss, &#x000a0;meningitis, encephalitis, or SIADH (syndrome of inappropriate secretion of Antidiuretic hormone). Lab findings surprisingly show a normal eosinophil count along with low serum albumin and anemia. Hyper infection syndrome and disseminated disease have a mortality rate of up to 80 to&#x000a0; 90% <xref ref-type="bibr" rid="article-29577.r11">[11]</xref><xref ref-type="bibr" rid="article-29577.r12">[12]</xref><xref ref-type="bibr" rid="article-29577.r13">[13]</xref></p>
      </sec>
      <sec id="article-29577.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The concept of asymptomatic screening is particularly relevant in lower socioeconomic status individuals in high endemic areas, individuals being started on planned immunosuppression with systemic steroids or post solid organ transplants, and also in individuals with hitherto unexplained persistent eosinophilia.<xref ref-type="bibr" rid="article-29577.r14">[14]</xref></p>
        <p>&#x000a0;The microscopic examination of stool for larval forms still remains the gold standard of diagnosis.&#x000a0;However, a single stool exam has only about 50% sensitivity.</p>
        <p>Sporadic excretion of larva in stool makes microscopic stool testing a very unpredictable and low-yield diagnostic tool. It is somewhat mitigated by serial stool testing. The sensitivity of serial stool samples reaches 100% when 7 samples, each from different days, are tested.<xref ref-type="bibr" rid="article-29577.r15">[15]</xref>&#x000a0;Several techniques have been applied over the years to enhance the detection of larvae in stool, including the Baermann method and the Harada- Mori method.<xref ref-type="bibr" rid="article-29577.r16">[16]</xref>&#x000a0;The blood agar plate culture method has the highest sensitivity ( 96%) among stool exam techniques.<xref ref-type="bibr" rid="article-29577.r17">[17]</xref>&#x000a0;Serologic testing by recombinant antigens is more sensitive but suffers from a lack of availability, particularly in endemic areas in the developing world. The rSs1a recombinant antigen has demonstrated a sensitivity of 96% and specificity of 93%.<xref ref-type="bibr" rid="article-29577.r18">[18]</xref>&#x000a0; Microscopic visualization of the larva can also be used for other body fluids like bronchoalveolar lavage fluid, cerebrospinal fluid, pleural fluid, or even duodenal biopsy. <xref ref-type="bibr" rid="article-29577.r19">[19]</xref>&#x000a0;Real-time polymerase chain reaction can also be used for body fluid samples and stool.</p>
        <p>Diagnostic sensitivity is enhanced by combining stool testing with serologic testing by Enzyme-linked Immunosorbent assay( ELISA). ELISA&#x000a0; has a high negative predictive value and can thus help in ruling out infection, particularly in patients to be subjected to immunosuppressive treatment. However, it identifies IgG and thus does not distinguish between current and prior infection.</p>
        <p>IgG antibodies can also be detected by the indirect Immunofluorescent antibody test (IFAT). A 1:20 titer or above has a sensitivity of 97.4% and a specificity of 97.9%. It is, therefore, the desired cutoff for screening. Luciferase immunoprecipitation system (LIPS) &#x000a0;provides the highest positive predictive value with a specificity of 100%.<xref ref-type="bibr" rid="article-29577.r20">[20]</xref><xref ref-type="bibr" rid="article-29577.r21">[21]</xref>&#x000a0;It detects antibodies to a recombinant Strongyloides antigen.</p>
        <p>The diagnosis of hyperinfection syndrome is relatively easy because of the high larval load in the stool or body fluids.&#x000a0;</p>
        <p>Endoscopy and duodenal biopsy may reveal larva or signs of chronic inflammation like edematous mucosa, white villi, or erythematous mucosa.</p>
        <p>High serum IgE levels are present in 39% to 58% of the cases. This association between elevated serum IgE levels and strongyloidiasis is, however, rarely present in &#x000a0;HTLV-1 co-infected individuals, indicating an inability of HTLV-I-positive patients to clear<italic toggle="yes"> S. stercoralis.</italic></p>
      </sec>
      <sec id="article-29577.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Many studies show that the&#x000a0;best treatment for uncomplicated strongyloidiasis is a drug called Ivermectin.&#x000a0;The recommended treatment regimen consists of 200 mcg/kg for 2 consecutive days. For uncomplicated strongyloidiasis, the treatment is ivermectin daily until larvae can no longer be detected in stool, urine, or sputum for two weeks.<xref ref-type="bibr" rid="article-29577.r22">[22]</xref><xref ref-type="bibr" rid="article-29577.r23">[23]</xref><xref ref-type="bibr" rid="article-29577.r24">[24]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Ivermectin does not kill the Strongyloides larvae, but only the adult worms. As a result, repeat dosing is necessary.</p>
          </list-item>
          <list-item>
            <p>There is an auto-infective cycle of about 2 weeks in which ivermectin must be re-administered, and additional dosing will be necessary as it will not kill Strongyloides in the blood or larvae deep within the bowels.</p>
          </list-item>
          <list-item>
            <p>Ivermectin is metabolized by the cytochrome P450 3A4 pathway in the liver, and therefore patient with hepatobiliary impairment needs to explore other options for therapy. It targets both the adult and larval stages, while albendazole targets only the adult stage of the parasite</p>
          </list-item>
          <list-item>
            <p>Albendazole and thiabendazole (25 mg/kg twice daily for 5 days, a 400 mg maximum) are also effective.</p>
          </list-item>
          <list-item>
            <p>The optimal duration of treatment is not clear.</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Albendazole can suppress bone marrow and thus result in pancytopenia</p>
          </list-item>
          <list-item>
            <p>Eradication can be difficult as Strongyloides has been known to live in individuals for decades, even after treatment.</p>
          </list-item>
          <list-item>
            <p>Continued treatment is often necessary, even if symptoms resolve.</p>
          </list-item>
          <list-item>
            <p>Clothes and sheets should be&#x000a0;washed with enzyme washing powder and dried on hot days.</p>
          </list-item>
        </list>
        <p>For patients with hyperinfection syndrome, contact precautions and isolation are recommended, as larvae may be found in all body fluids. Family members should also be screened, and healthcare workers should adopt universal precautions. Steroids and leukotriene inhibitors should be avoided as leukotrienes play a potential role in immunity against Strongyloides infection.</p>
        <p>Ivermectin is pregnancy category C and is thus not recommended for pregnant or lactating women unless no other option of treatment is available. Albendazole is allowed by WHO in the last 2 trimesters of pregnancy, although it is also pregnancy category C in the USA. If a new treatment is being initiated, pregnancy testing should be completed.</p>
        <p>Ivermectin is also not recommended for body weight less than 15 kg, and therefore, albendazole is the recommended treatment at a dose of 400 mg daily for 3 days between age 2 to 20 and 200 mg daily for 3 days below age 2.<xref ref-type="bibr" rid="article-29577.r25">[25]</xref>&#x000a0;</p>
        <p>
<bold>Intensive Care</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Immunocompromised patients may require intensive care for disseminated infection.</p>
          </list-item>
          <list-item>
            <p>Contact isolation should be considered because sputum, stool, and vomitus may contain infective larvae.</p>
          </list-item>
          <list-item>
            <p>Patients with hyperinfection syndrome often have sepsis, shock, and acute respiratory distress syndrome (ARDS).</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29577.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute respiratory distress syndrome</p>
          </list-item>
          <list-item>
            <p>Asthma</p>
          </list-item>
          <list-item>
            <p>Cholera</p>
          </list-item>
          <list-item>
            <p>Chronic obstructive pulmonary disease</p>
          </list-item>
          <list-item>
            <p>Diverticulitis</p>
          </list-item>
          <list-item>
            <p>Ileus</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Loeffler syndrome</p>
          </list-item>
          <list-item>
            <p>Peritonitis</p>
          </list-item>
          <list-item>
            <p>Pneumonia, especially in the immunocompromised</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29577.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis in strongyloidiasis depends on the development of complications. Strongyloidiasis can result in dermatologic, gastrointestinal, renal, pulmonary, and neurologic complications and even death.</p>
        <p>
<bold>Gastrointestinal</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Appendicitis</p>
          </list-item>
          <list-item>
            <p>Eosinophilic oophoritis</p>
          </list-item>
          <list-item>
            <p>Hemorrhage</p>
          </list-item>
          <list-item>
            <p>Ileus</p>
          </list-item>
          <list-item>
            <p>Infarction</p>
          </list-item>
          <list-item>
            <p>Intestinal obstruction</p>
          </list-item>
          <list-item>
            <p>Malabsorption</p>
          </list-item>
          <list-item>
            <p>Obstructive jaundice</p>
          </list-item>
          <list-item>
            <p>Perforation</p>
          </list-item>
          <list-item>
            <p>Peritonitis</p>
          </list-item>
          <list-item>
            <p>Pneumatosis intestinalis&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Pulmonary</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Alveolar hemorrhage</p>
          </list-item>
          <list-item>
            <p>Asthma</p>
          </list-item>
          <list-item>
            <p>ARDS</p>
          </list-item>
          <list-item>
            <p>Granulomatous lung disease</p>
          </list-item>
          <list-item>
            <p>Pneumonitis</p>
          </list-item>
          <list-item>
            <p>Respiratory failure</p>
          </list-item>
          <list-item>
            <p>Pleural effusion</p>
          </list-item>
        </list>
        <p>
<bold>Dermatologic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic urticaria</p>
          </list-item>
          <list-item>
            <p>Larva currens</p>
          </list-item>
          <list-item>
            <p>Purpura of the trunk and proximal extremities</p>
          </list-item>
        </list>
        <p>
<bold>Neurologic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Brain abscess</p>
          </list-item>
          <list-item>
            <p>Meningitis</p>
          </list-item>
          <list-item>
            <p>Vascular Complications</p>
          </list-item>
          <list-item>
            <p>Hyperinfection syndrome presenting as bacteremia</p>
          </list-item>
        </list>
        <p>
<bold>Renal Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nephrotic syndrome</p>
          </list-item>
          <list-item>
            <p>Syndrome of inappropriate antidiuretic hormone (SIADH)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29577.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications may include the development of respiratory problems (Loeffler syndrome), digestive issues, and hyperinfection may result in central nervous system problems. Chronic disseminated strongyloidiasis is associated with immunodepression.<xref ref-type="bibr" rid="article-29577.r26">[26]</xref><xref ref-type="bibr" rid="article-29577.r27">[27]</xref></p>
      </sec>
      <sec id="article-29577.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The goal in strongyloidiasis is to eradicate the infection, decrease morbidity, and prevent complications.</p>
        <list list-type="bullet">
          <list-item>
            <p>Albendazole and mebendazole are sometimes used in Strongyloides stercoralis infection, but results&#x000a0;are&#x000a0;varied.</p>
          </list-item>
          <list-item>
            <p>Ivermectin is&#x000a0;more effective than albendazole.</p>
          </list-item>
          <list-item>
            <p>The disseminated disease should be treated with ivermectin. For those too sick to tolerate oral ivermectin, subcutaneous or rectal dosing may be effective.</p>
          </list-item>
          <list-item>
            <p>Ivermectin should be administered daily until symptoms have resolved and larvae have not been detected for at least 2 weeks.</p>
          </list-item>
        </list>
        <p>Parasite pathways are different from the human host and allow selective interference by chemotherapeutic agents. The effectiveness of anthelmintic agents against larvae is poor; they are more effective&#x000a0;in established infection.</p>
        <p>
<bold>Ivermectin</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Ivermectin is the drug of choice for both acute and chronic strongyloidiasis in intestinal stages, hyperinfection syndrome, and disseminated strongyloidiasis.</p>
          </list-item>
          <list-item>
            <p>This drug has not been studied extensively in children, and it has been used as an adjuvant in patients with hyperinflation not responding to thiabendazole.</p>
          </list-item>
          <list-item>
            <p>Ivermectin is a semisynthetic macrolide that binds selectively to glutamate-gated chloride ion channels in nerve and muscle cells, increasing cell membrane permeability with hyperpolarization and causing paralysis and cell death.</p>
          </list-item>
          <list-item>
            <p>Ivermectin's&#x000a0;half-life is 16 hours, and it is metabolized in the liver.</p>
          </list-item>
          <list-item>
            <p>The cure rate is close to 100% with a&#x000a0;2-day course.</p>
          </list-item>
        </list>
        <p>
<bold>Albendazole</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Albendazole is an alternative to ivermectin for acute&#x000a0;and chronic strongyloidiasis.</p>
          </list-item>
          <list-item>
            <p>Albendazole has a high affinity for binding free beta-tubulin in the parasite's cells&#x000a0;and inhibiting tubulin polymerization, resulting in loss of cytoplasmic microtubules and decreasing ATP production in the worm, which results in energy depletion by inhibiting glucose uptake, immobilization, then causing death.</p>
          </list-item>
          <list-item>
            <p>Albendazole&#x000a0;should be administered with high-dose glucocorticoids and anticonvulsants to avoid a central nervous system inflammatory response.</p>
          </list-item>
        </list>
        <p>
<bold>Mebendazole</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Mebendazole has variable efficacy against strongyloidiasis.</p>
          </list-item>
          <list-item>
            <p>This agent inhibits microtubule formation and causes worm glucose depletion, and is available in chewable form for pediatric use.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29577.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of Strongyloides infection are done with an interprofessional team that includes an infectious disease expert, gastroenterologist, emergency department physician, and pharmacist. The key is to get rid of all larvae with ivermectin. Once discharged, the patients need to follow up&#x000a0;with either a nurse practitioner or primary physician to ensure that all body fluids have no remnant larvae. Patients also need to be educated about handwashing and maintaining personal hygiene. For those with a simple infection of the GI tract, the outcomes are good, but in patients with multiple organ infestations, the prognosis is guarded.<xref ref-type="bibr" rid="article-29577.r28">[28]</xref><xref ref-type="bibr" rid="article-29577.r29">[29]</xref></p>
      </sec>
      <sec id="article-29577.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29577&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29577">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29577/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29577">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29577.s14">
        <title>References</title>
        <ref id="article-29577.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barroso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salvador</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Montalv&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bosch-Nicolau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Molina</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis infection: A systematic review of endemic cases in Spain.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>e0007230</fpage>
            <pub-id pub-id-type="pmid">30860995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bour&#x000e9;e</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Usubillaga</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Viard</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Slama</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salmon</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Strongyloidiasis, a sexually transmitted disease].</article-title>
            <source>Presse Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>3 Pt 1</issue>
            <fpage>322</fpage>
            <page-range>322-324</page-range>
            <pub-id pub-id-type="pmid">30853289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camargo</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Simkins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Anjan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vianna</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Albright</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shipman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Montoya</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Abbo</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Implementation of a Strongyloides screening strategy in solid organ transplant donors and recipients.</article-title>
            <source>Clin Transplant</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>e13497</fpage>
            <pub-id pub-id-type="pmid">30773692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaya</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>&#x00130;nkaya</surname>
                <given-names>A&#x000c7;</given-names>
              </name>
              <name>
                <surname>Ertenli</surname>
                <given-names>A&#x00130;</given-names>
              </name>
              <name>
                <surname>Abbaso&#x0011f;lu</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Aksoy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aky&#x000f6;n Y&#x00131;lmaz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Erg&#x000fc;ven</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The investigation of Strongyloides stercoralis seroprevalence in immunosupressed patients in Turkey.</article-title>
            <source>Turk J Med Sci</source>
            <year>2019</year>
            <month>Feb</month>
            <day>11</day>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-19</page-range>
            <pub-id pub-id-type="pmid">30761833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greenaway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Castelli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Migration Medicine.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>265</fpage>
            <page-range>265-287</page-range>
            <pub-id pub-id-type="pmid">30712766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krolewiecki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nutman</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Strongyloidiasis: A Neglected Tropical Disease.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>135</fpage>
            <page-range>135-151</page-range>
            <pub-id pub-id-type="pmid">30712758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazigo</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Strongyloidiasis and schistosomiasis: lessons from migrants' data.</article-title>
            <source>Lancet Glob Health</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>e171</fpage>
            <page-range>e171-e172</page-range>
            <pub-id pub-id-type="pmid">30683227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caruana</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Ngeow</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chea</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nuon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bak</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Skull</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Biggs</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia.</article-title>
            <source>J Travel Med</source>
            <year>2006</year>
            <season>Jul-Aug</season>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>233</fpage>
            <page-range>233-9</page-range>
            <pub-id pub-id-type="pmid">16884406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greaves</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Coggle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pollard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aliyu</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis infection.</article-title>
            <source>BMJ</source>
            <year>2013</year>
            <month>Jul</month>
            <day>30</day>
            <volume>347</volume>
            <fpage>f4610</fpage>
            <pub-id pub-id-type="pmid">23900531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Maxfield</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Crane</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <chapter-title>Cutaneous Larva Migrans</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">29939528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farthing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Albonico</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bundy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Buonfrate</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chiodini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Katelaris</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Savioli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mair</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>World Gastroenterology Organisation Global Guidelines: Management of Strongyloidiasis February 2018-Compact Version&#x0003e;.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>54</volume>
            <issue>9</issue>
            <fpage>747</fpage>
            <page-range>747-757</page-range>
            <pub-id pub-id-type="pmid">32890112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alsager</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Waqar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Furrukh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alattas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Donor-derived strongyloidiasis in a Saudi pediatric kidney transplant recipient: A case report and mini-review.</article-title>
            <source>Pediatr Transplant</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>e13315</fpage>
            <pub-id pub-id-type="pmid">30578622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buonfrate</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Formenti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perandin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Novel approaches to the diagnosis of Strongyloides stercoralis infection.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>543</fpage>
            <page-range>543-52</page-range>
            <pub-id pub-id-type="pmid">25887711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramos-Sesma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Llenas-Garc&#x000ed;a</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gil-Anguita</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Torr&#x000fa;s-Tendero</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wikman-Jorgensen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Amador-Prous</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ventero-Mart&#x000ed;n</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Garijo-Sainz</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-L&#x000f3;pez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pujades-T&#x000e1;rraga</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Bernal-Alcaraz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Santonja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guevara-Hern&#x000e1;ndez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Flores-Ch&#x000e1;vez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saugar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ramos-Rinc&#x000f3;n</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Corazones Sin Chagas Platform</surname>
              </name>
            </person-group>
            <article-title>Asymptomatic Strongyloidiasis among Latin American Migrants in Spain: A Community-Based Approach.</article-title>
            <source>Pathogens</source>
            <year>2020</year>
            <month>Jun</month>
            <day>24</day>
            <volume>9</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">32599871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddiqui</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Berk</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Strongyloides stercoralis infection.</article-title>
            <source>Clin Infect Dis</source>
            <year>2001</year>
            <month>Oct</month>
            <day>01</day>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>1040</fpage>
            <page-range>1040-7</page-range>
            <pub-id pub-id-type="pmid">11528578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunathilaka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chandrasena</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wijerathna</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fuji</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gunasekara</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gunatilaka</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Premaratna</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Descriptive Investigation of Strongyloidiasis Infection and Characterization of <italic>Strongyloides stercoralis</italic> Using Morphological and Molecular-Based Methods.</article-title>
            <source>Case Rep Infect Dis</source>
            <year>2020</year>
            <volume>2020</volume>
            <fpage>5431491</fpage>
            <pub-id pub-id-type="pmid">32884851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>In&#x000ea;s</surname>
                <given-names>Ede J</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of parasitological methods for the diagnosis of Strongyloides stercoralis and hookworm in faecal specimens.</article-title>
            <source>Acta Trop</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>120</volume>
            <issue>3</issue>
            <fpage>206</fpage>
            <page-range>206-10</page-range>
            <pub-id pub-id-type="pmid">21896267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arifin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yunus</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Nolan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Lok</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Noordin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Identification and Preliminary Evaluation of a Novel Recombinant Protein for Serodiagnosis of Strongyloidiasis.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>98</volume>
            <issue>4</issue>
            <fpage>1165</fpage>
            <page-range>1165-1170</page-range>
            <pub-id pub-id-type="pmid">29436335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nutman</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Human infection with Strongyloides stercoralis and other related Strongyloides species.</article-title>
            <source>Parasitology</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>144</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <page-range>263-273</page-range>
            <pub-id pub-id-type="pmid">27181117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boscolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gobbo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Degani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anselmi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Monteiro</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Marocco</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Angheben</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mistretta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Santacatterina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tais</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up.</article-title>
            <source>Clin Vaccine Immunol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-33</page-range>
            <pub-id pub-id-type="pmid">17135451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pritchard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hemmige</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bautista</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Damania</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ricciardi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nutman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Mejia</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis Infection in Solid Organ Transplant Patients Is Associated With Eosinophil Activation and Intestinal Inflammation: A Cross-sectional Study.</article-title>
            <source>Clin Infect Dis</source>
            <year>2020</year>
            <month>Dec</month>
            <day>17</day>
            <volume>71</volume>
            <issue>10</issue>
            <fpage>e580</fpage>
            <page-range>e580-e586</page-range>
            <pub-id pub-id-type="pmid">32155244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asundi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beliavsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Akaberi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwarzer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Requena-M&#x000e9;ndez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shrier</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Greenaway</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis.</article-title>
            <source>Lancet Glob Health</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>e236</fpage>
            <page-range>e236-e248</page-range>
            <pub-id pub-id-type="pmid">30683241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agbata</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Morton</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bottieau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Greenaway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Biggs</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Montero</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rowbotham</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arevalo-Rodriguez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Myran</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Noori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Alonso-Coello</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pottie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Requena-M&#x000e9;ndez</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2018</year>
            <month>Dec</month>
            <day>20</day>
            <volume>16</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30577567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Page</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Judd</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>The Unique Life Cycle of Strongyloides stercoralis and Implications for Public Health Action.</article-title>
            <source>Trop Med Infect Dis</source>
            <year>2018</year>
            <month>May</month>
            <day>25</day>
            <volume>3</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30274449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>John</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Bjerum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Likia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Silus</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Elizah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chhonker</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Bala</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Murry</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Mitja</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases.</article-title>
            <source>Clin Infect Dis</source>
            <year>2020</year>
            <month>Aug</month>
            <day>20</day>
            <pub-id pub-id-type="pmid">32818264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashida</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nozaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Funauchi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.</article-title>
            <source>BMC Infect Dis</source>
            <year>2020</year>
            <month>Jul</month>
            <day>02</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>470</fpage>
            <pub-id pub-id-type="pmid">32615937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norman</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Chamorro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Comeche</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Molina</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-V&#x000e9;lez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Update on the major imported helminth infections in travelers and migrants.</article-title>
            <source>Future Microbiol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>15</volume>
            <fpage>437</fpage>
            <page-range>437-444</page-range>
            <pub-id pub-id-type="pmid">32250168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wo&#x00142;yniec</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sulima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Renke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D&#x00119;bska-&#x0015a;lizie&#x00144;</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Parasitic Infections Associated with Unfavourable Outcomes in Transplant Recipients.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2018</year>
            <month>May</month>
            <day>01</day>
            <volume>54</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30344258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29577.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mileo Bacelar Guerreiro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tavares Sodr&#x000e9;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brand&#x000e3;o Pavan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Feij&#x000f3; Barroso</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carvalho Quintella</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cuzzi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ramos-E-Silva</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Disseminated Strongyloidiasis.</article-title>
            <source>Acta Dermatovenerol Croat</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>333</fpage>
            <page-range>333-336</page-range>
            <pub-id pub-id-type="pmid">30665485</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
